ChemoMetec A/S (CHEMM)

Copenhagen
Currency in DKK
507.00
-15.00(-2.87%)
Closed
CHEMM Scorecard
Full Analysis
Impressive gross profit margins
Earnings results expected in 15 days
Fair Value
Day's Range
506.00521.00
52 wk Range
281.20563.00
Key Statistics
Edit
Prev. Close
507
Open
519.5
Day's Range
506-521
52 wk Range
281.2-563
Volume
20.93K
Average Volume (3m)
45.26K
1-Year Change
37.18%
Book Value / Share
32.48
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CHEMM Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
545.00
Upside
+7.50%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

ChemoMetec Company Profile

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas of cell and gene therapy, cancer and stem cell research, and development and manufacturing of pharmaceuticals, as well as production and quality control of animal semen, milk, and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer; NucleoCounter NC-250, an automated cell analyzer; NucleoCounter NC-202, a consistent cell counter; NucleoCounter NC-200, an automated cell counter that provides solution for cell counting and cell viability determination; NucleoCounter SP-100, an automated sperm cell counter for use in animal reproduction; and XcytoMatic 40, a cell density and viability analyzer. In addition, the company provides consumables comprising cassettes, reagents, lysis, and slides; accessories, which include cables, power supplies, software, and labware products, as well as service and validation plans and training. Further, it develops as well as develops XcytoMatic 30 cell counter. ChemoMetec A/S was incorporated in 1997 and is headquartered in Allerød, Denmark.

Employees
174
Market
Denmark

Compare CHEMM to Peers and Sector

Metrics to compare
CHEMM
Peers
Sector
Relationship
P/E Ratio
62.9x33.8x−0.6x
PEG Ratio
−2.80−0.720.00
Price/Book
15.2x3.3x2.6x
Price / LTM Sales
21.0x4.3x3.1x
Upside (Analyst Target)
4.8%25.5%54.6%
Fair Value Upside
Unlock8.2%7.7%Unlock

Analyst Ratings

2 Buy
1 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 545.00
(+7.50% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 7.83
Dividend Yield
0.79%
Industry Median 1.78%
Annualised payout
4
Paid annually
5-Years Growth
-11.81%
Growth Streak

Earnings

Latest Release
Nov 07, 2024
EPS / Forecast
3.56 / 2.88
Revenue / Forecast
115.80M / 104.60M
EPS Revisions
Last 90 days

People Also Watch

148.80
ALKb
-1.26%
79.40
LTEN
-0.38%
55.50
TXTP
+1.83%
11.12
BO
-2.46%
199.40
CBRAIN
+7.55%

FAQ

What Is the ChemoMetec (CHEMM) Stock Price Today?

The ChemoMetec stock price today is 507.00

What Stock Exchange Does ChemoMetec Trade On?

ChemoMetec is listed and trades on the Copenhagen stock exchange.

What Is the Stock Symbol for ChemoMetec?

The stock symbol for ChemoMetec is "CHEMM."

Does ChemoMetec Pay Dividends? What’s The Current Dividend Yield?

The ChemoMetec dividend yield is 0.79%.

What Is the ChemoMetec Market Cap?

As of today, ChemoMetec market cap is 8.82B.

What is ChemoMetec Earnings Per Share?

The ChemoMetec EPS is 7.83.

What Is the Next ChemoMetec Earnings Date?

ChemoMetec will release its next earnings report on 05 Feb 2025.

From a Technical Analysis Perspective, Is CHEMM a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.